Literature DB >> 11420305

Distinct pathways of Ca(2+) sensitization in porcine coronary artery: effects of Rho-related kinase and protein kinase C inhibition on force and intracellular Ca(2+).

K Nobe1, R J Paul.   

Abstract

Alterations of the Ca(2+) sensitivity of contraction have been reported for porcine coronary artery, but the mechanisms are not clearly understood. We investigated the mechanism(s) of Ca(2+) sensitization in response to the thromboxane A(2) analogue (U46619). Our hypothesis is that different mechanisms of Ca(2+) sensitization could be distinguished by their distinct time courses. Therefore, we measured the time course of [Ca(2+)](i) and isometric force simultaneously in an intact artery after a single addition of U46619. The initial transient phase was associated with Ca(2+) release from the sarcoplasmic reticulum, whereas the maintained phase was associated with Ca(2+) influx. Two distinct types of Ca(2+) sensitization characterized these phases with either protein kinase C (PKC)-mediated or Rho-kinase-mediated mechanisms. Their effects were quite distinct on the basis of the time courses over which the sensitization was effective. PKC inhibition (1 micromol/L calphostin C) had a much greater effect in the initial phase, diminishing the size of the transient and prolonging the rise in force and the decline in [Ca(2+)](i). There were limited effects on the sustained force. Rho-kinase inhibition (10 micromol/L Y27632), in contrast, nearly abolished the sustained force but had a lesser effect on the transient phase. Neither inhibitor had any effect on the force versus [Ca(2+)](i) relations for KCl contractures. Our evidence suggests that both PKC-mediated and Rho-kinase-mediated Ca(2+) sensitizations are present in coronary arteries, but the latter is dominant in thromboxane A(2) receptor-mediated contraction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420305     DOI: 10.1161/hh1201.092035

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

1.  Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.

Authors:  Koji Nobe; Mari Miyatake; Hiromi Nobe; Yasushi Sakai; Junko Takashima; Kazutaka Momose
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

2.  Ca2+-desensitizing hypoxic vasorelaxation: pivotal role for the myosin binding subunit of myosin phosphatase (MYPT1) in porcine coronary artery.

Authors:  Robert L Wardle; Min Gu; Yukisato Ishida; Richard J Paul
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

3.  Vasoconstrictor stimulus determines the functional contribution of myoendothelial feedback to mesenteric arterial tone.

Authors:  R Wei; S E Lunn; R Tam; S L Gust; B Classen; P M Kerr; F Plane
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

4.  Differential inhibition by the Rho kinase inhibitor Y-27632 of the increases in contractility and Ca2+ transients induced by endothelin-1 in rabbit ventricular myocytes.

Authors:  Li Chu; Ikuo Norota; Masao Endoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-20       Impact factor: 3.000

5.  Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery.

Authors:  Anthie Ellis; Malarvannan Pannirselvam; Todd J Anderson; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

6.  PKC and Rho in vascular smooth muscle: activation by BOXes and SAH CSF.

Authors:  Gail J Pyne-Geithman; Sunil G Nair; Danielle N Caudell; Joseph F Clark
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.

Authors:  Karl Swärd; Mitsuo Mita; David P Wilson; Jing Ti Deng; Marija Susnjar; Michael P Walsh
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries.

Authors:  Philippe Ghisdal; Greet Vandenberg; Nicole Morel
Journal:  J Physiol       Date:  2003-07-09       Impact factor: 5.182

9.  Thromboxane A2-induced bi-directional regulation of cerebral arterial tone.

Authors:  Ronald L Neppl; Lubomir T Lubomirov; Ko Momotani; Gabriele Pfitzer; Masumi Eto; Avril V Somlyo
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

10.  Chronic in utero cyclooxygenase inhibition alters PGE2-regulated ductus arteriosus contractile pathways and prevents postnatal closure.

Authors:  Jeff Reese; Nahid Waleh; Stanley D Poole; Naoko Brown; Christine Roman; Ronald I Clyman
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.